MoneyWorks4Me

ICRA upgrades ratings assigned to Hikal’s bank facilities

14 Nov 2016 Evaluate

Credit Rating agency, ICRA has upgraded rating assigned to Hikal’s long-term rating to ‘BBB+’ from ‘BBB’ with stable outlook. The credit rating agency has also reaffirmed rating assigned to company’s short term rating of A2.

Hikal is engaged in R&D, manufacturing and marketing of fine chemicals for the Pharmaceutical and Agrochemical industries. It collaborates with innovator companies and offer solutions in Contract Research, Custom Synthesis and Custom Manufacturing. Its people have extensive expertise in multi-disciplinary project management.


Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..